Clinical Trials Directory

Trials / Completed

CompletedNCT04610957

Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
FAlbasri · Other Government
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This prospective, randomized clinical trial double blinded study, has been carried on 160 infertile patients seeking pregnancy in Gynecology and Obstetrics Department, Zagazig University Hospitals during the period from January 2019 to November 2019, the participants' randomizations were done and patients divided into two groups; group I: included 80 women receiving Clomiphene citrate (CC) plus Isoflavonoids. Group 2: included 80 women receiving Clomiphene citrate only

Detailed description

Phytoestrogens continue to be of increasing interest because of their possible influence on the physiology of the reproductive tract. The aim of Prospective randomized clinical trial study is to evaluate effect of adding isoflavonoids to clomiphene citrate during ovulation induction in women with PCOS on the endometrial thickness which has an impact on pregnancy rate. This study included 160 infertile women seeking pregnancy and they were divided into two groups. Clomiphene is given orally at dose, one tablet twice per day (tablet 50 mg), from day 3 to day 7 for all patients (group I and group II),while phytoestrogens are given at dose, two tablets two times per day (tablet 800mg), from day 3 to day 12 only for group I, followed by HCG injection on attaining mature follicle(s) by trans-vaginal US scan with diameter ≥ 18 mm.

Conditions

Interventions

TypeNameDescription
DRUGRosafem (FEMININE FORMULA)Rosafem is the only phytoestrogen product with the convenient dose which provides significant improvement of menopausal related symptoms premenstrual syndrome symptoms

Timeline

Start date
2019-01-01
Primary completion
2019-01-01
Completion
2019-04-10
First posted
2020-11-02
Last updated
2020-11-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04610957. Inclusion in this directory is not an endorsement.